Intuitive Surgical, Inc.

NasdaqGS ISRG

Intuitive Surgical, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 7.87 B

Intuitive Surgical, Inc. Revenue is USD 7.87 B for the Trailing 12 Months (TTM) ending September 30, 2024, a 14.83% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Intuitive Surgical, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 6.85 B, a 11.98% change year over year.
  • Intuitive Surgical, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 6.12 B, a 11.47% change year over year.
  • Intuitive Surgical, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 5.49 B, a 27.43% change year over year.
  • Intuitive Surgical, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 4.31 B, a 1.41% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NasdaqGS: ISRG

Intuitive Surgical, Inc.

CEO Dr. Gary S. Guthart Ph.D.
IPO Date June 16, 2000
Location United States
Headquarters 1020 Kifer Road
Employees 13,676
Sector Health Care
Industries
Description

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Similar companies

STXS

Stereotaxis, Inc.

USD 2.07

-0.48%

RGEN

Repligen Corporation

USD 156.55

-1.19%

COO

The Cooper Companies, Inc.

USD 89.11

-2.38%

TFX

Teleflex Incorporated

USD 179.17

0.35%

EMBC

Embecta Corp.

USD 20.10

0.95%

WST

West Pharmaceutical Services, Inc.

USD 328.96

-3.13%

BDX

Becton, Dickinson and Company

USD 235.80

-0.17%

RMD

ResMed Inc.

USD 228.83

-0.62%

MMSI

Merit Medical Systems, Inc.

USD 99.89

4.44%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

HOLX

Hologic, Inc.

USD 70.20

-0.13%

LUCY

Innovative Eyewear, Inc.

USD 5.73

2.69%

BAX

Baxter International Inc.

USD 30.62

0.39%

NXGL

NEXGEL, Inc.

USD 3.45

-2.27%

StockViz Staff

January 15, 2025

Any question? Send us an email